The Neglected Dimension of Global Security A Framework to Counter Infectious Disease Crises (2016) / Chapter Skim
Currently Skimming:
Appendix B: Workshop Agendas
Appendix B: Workshop Agendas
Pages 91-108
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 91... ...
, USA Session I: Opening Plenary: Lessons from a Historical Perspective Session Moderator: Gabriel Leung, Dean, Li Ka Shing Faculty of Medicine, The University of Hong Kong; Workshop Planning Committee 9:10–10:30 Case Study Panel Presentation Rob Fowler, Physician, University of Toronto, Canada Jane Ruth Aceng, Director General of Health Services, Ministry of Health, Kampala, Uganda Trish M Perl, Division of Infectious Diseases, Department of Medicine, Johns Hopkins University, USA 10:30–11:00 Break 91
|
From page 92... ...
Executive Director, Global Health Workforce Alliance Focus Area 3: Health Care and Public Health Integration Facilitator: P Gregg Greenough, Research Director, Harvard Humanitarian Initiative, Harvard School of Public Health Koku Awoonor-Williams, Regional Director of Health Service for the Upper East Region of Ghana Focus Area 4: Community Engagement Facilitator: Ben Adeiza Adinoyi, Africa Zone Health and Care Coordinator, International Federation of Red Cross and Red Crescent Societies; Workshop Planning Committee Mosoka Fallah, Co-Principal Investigator: Ebola Natural History Study; US Liberian Research Partnership/NIAID, Liberia Janet Nakuti, Senior Program Officer, Monitoring and Documentation, Raising Voices, Kampala Uganda 3:30–4:00 Break
|
From page 93... ...
Business/Private Sector Graham Davidson, Managing Director, Simandou Project, Guinea, Rio Tinto Nana Yaa Afriyie Ofori-Koree, Foundation and Sustainability Manager, Vodafone Ghana Foundation Nongovernmental Organization (NGO) /Civil Society Saran Kaba Jones, Founder and Executive Director, FACEAfrica, Liberia 10:15–10:45 Break
|
From page 94... ...
9:00–9:15 am Welcome Michael Myers Francis Omaswa
|
From page 95... ...
8:40 am Welcome Gabriel Leung, Li Ka Shing Faculty of Medicine, The University of Hong Kong Victor Dzau, National Academy of Medicine
|
From page 96... ...
• Discuss challenges to building and sustaining more effective business models and public private partnerships; explore promising approaches and identify key attributes of a well working collaborative approach. 9:30 Segment A: Existing and Promising Incentives Keynote Lecture BT Slingsby, Global Health Innovative Technologies Fund Panel Discussion Lynn Marks, GlaxoSmithKline Rajeev Venkayya, Takeda Pharmaceuticals Kevin Outterson, Boston University 10:50 Break 11:00 Segment B: Sustainable and Effective Business Models and Public–Private Partnerships Keynote Lectures David Reddy, Medicines for Malaria Venture Krishna Ella, Bharat Biotech International Limited Panel Discussion Mel Spigelman, TB Alliance Graeme Bilbe, Drugs for Neglected Diseases Initiative Peter Dull, The Bill & Melinda Gates Foundation 12:30 pm Lunch Session 2: Science and Regulatory Convergence and Capacity Moderator: Maria Freire, Foundation for the National Institutes of Health Objectives: • Review and characterize the needs and gaps in current scientific tools, technologies, and capacities to de velop and evaluate products.
|
From page 97... ...
1:30 Segment A: State of the Science Keynote Lectures Michael Pfleiderer, Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines Trevor Mundel, The Bill & Melinda Gates Foundation Panel Discussion Margaret Hamburg, National Academy of Medicine Rudi Pauwels, BioCartis NV Charles Goldstein, Becton Dickinson Adel Mahmoud, Princeton University Craig E Colton, 3M Personal Safety Division 3:00 Segment B: Sharing of Data and Reagents, Intellectual Property and Liability Keynote Lecture Anthony So, Duke University Panel Discussion Michelle Mulder, South African Medical Research Council Lynn Marks, GlaxoSmithKline Reid Adler, Practical Innovation Strategy 4:20 Break 4:30 Segment C: Global Regulatory Convergence and Capacity Keynote Lectures Margaret Hamburg Hans-Georg Eichler, European Medicines Agency Panel Discussion Raymond Chua, Singapore Health Sciences Authority Mike Ward, WHO 6:00 Adjourn
|
From page 98... ...
• Consider ethical and methodological standards that may be used to determine optimal trial designs for assessing the readiness of investigational medical products prior to broader deployment during public health emergency. • Highlight strategies for engaging communities during times of public health emergency to determine how and when to undertake controlled clinical assessment and, where trials are used, to facilitate rapid and fair enrollment in trials for investigational products.
|
From page 99... ...
• Discuss the ethical considerations of different manufacturing approaches and deployment capabilities. 1:30 Segment A: Manufacturing and Stockpiling Keynote Lecture Rajeev Venkayya, Takeda Pharmaceuticals Discussion Panel Krishna Ella, Bharat Biotech International Limited Shanelle Hall, UNICEF 2:50 Break 3:00 Segment B: Supply Chain Mechanisms and Deployment Keynote Lecture David Ripin, Clinton Health Access Initiative (CHAI)
|
From page 100... ...
8:30–9:00 Welcome and Introductions Prashant Yadav, Vice President and Senior Research Fellow, William Davidson Institute, University of Michigan Victor Dzau, President, National Academy of Medicine 9:00–10:30 International Cooperative Action on Pandemics Moderator: Olga Jonas, Economic Adviser and Coordinator, Operational Response to Avian and Pandemic Influenzas, World Bank Gordon Woo, Catastrophist, Risk Management Solutions Jordan Tappero, Director Division of Global Health Protection, U.S. CDC Eduardo González Pier, Vice Minister Integration and Development, Ministry of Health, Mexico Aron Betru, CEO, Financing for Development 10:30–10:45 Break
|
From page 101... ...
José Ángel Villalobos, Senior Insurance Specialist, World Bank Gunther Kraut, Financial Solutions Life, Munich Re (by video) 1:15–2:15 Lunch 2:15–3:45 Innovative Financing for Preparedness and Response Moderator: Juan Costain, Lead Financial Specialist, World Bank Paolo Sison, Director Innovative Finance, Gavi, The Vaccine Alliance Christopher Egerton-Warburton, Partner, Lion's Head Global Partners Lelio Marmora, Executive Director, UNITAID Adam Bornstein, Specialist Innovative Health Financing, The Global Fund 3:45–4:00 Break Session III: Identifying Triggers and Modelling Risk Objective: To discuss a verifiable trigger for payout and a suitable group to adjudicate triggers, to understand what models can tell us about pandemic risk.
|
From page 102... ...
8:30–9:00 am Breakfast available 9:00–9:15 Welcome and Overview Prashant Yadav Session IV: Management and Administration of Funds Objective: To understand the constraints on donors and discuss how financial tools can be designed to encourage risk sharing and crowding in; to discuss the administrative burden emergency payments place recipient country governments. 9:15–10:45 Financing Challenges In-Country Moderator: Peter Sands Tendai Biti, Former Minister of Finance, Zimbabwe Gordon Liu, Yangtze River Scholar, Professor of Economics, National School of Development, Peking University Victor Bampoe, Deputy Minister of Health, Ghana James Kollie, Deputy Minister for Fiscal Affairs, Ministry of Finance and Development Planning, Liberia 10:45–11:00 Break 11:00 am–12:30 pm Donor Considerations and Crowding-In Moderator: Trish Stroman, Partner and Managing Director, BCG Tore Godal, Special Advisor, Office of the Prime Minister, Norway Jennifer Adams, Deputy Assistant Administrator, Bureau for Global Health, USAID Gargee Ghosh, Director Development Policy and Finance, The Bill & Melinda Gates Foundation Erin Hohlfelder, Policy Director Global Health, ONE Campaign 12:30–1:30 Lunch Session V: Financing Preparedness and Giving Incentives Objective: To explain how financial incentives can be used to encourage preparedness and health systems development.
|
From page 103... ...
8:00–8:30 am Registration and Continental Breakfast 8:30–8:40 Welcome Jeremy Farrar, Director, Wellcome Trust David Relman, Chair of the Forum on Microbial Threats, IOM; Professor of M icrobiology and Immunology, Stanford University 8:40–8:55 Overview of the Global Health Risk Framework Initiative Patrick Kelley, Director, Board on Global Health, IOM 8:55–9:00 Keynote Introduction David Relman 9:00–9:30 Keynote Remarks: Governance for Global Health -- Engaging Intergovernmental Organizations to Achieve Collection Action Keizo Takemi, Member of Japanese Parliament
|
From page 104... ...
10:10–10:30 Discussion 10:30–10:45 Break 10:45–11:45 Part 2: Lessons Learned from Outbreaks of the Past Case Study Panel David Heymann, Head/Chair, Public Health England/Chatham House Harvey Fineberg, President, Moore Foundation Joanne Liu, President, Médecins Sans Frontières 11:45 am–12:45 pm Discussion 12:45–1:30 Lunch Session II: Challenges in Governance for Global Health for Fragile States Session Moderator: Oyewale Tomori, President, Nigerian Academy of Science Objectives: • Compare and contrast different governance approaches for fragile health systems vs. other areas and identify where new approaches are relevant.
|
From page 105... ...
• Identify how global security initiatives and frameworks can work together to boost preparedness and response. 2:40–4:30 Presentations Charles Clift, Senior Consulting Fellow, Center on Global Health Security, Chatham House Margaret Chan, Director General, WHO Colin McIff, Senior Health Attaché, U.S.
|
From page 106... ...
John, WHO Consultant 10:05–10:20 Break 10:20–11:10 Presentations Ben Anyene, Chairman, Health Reform Foundation of Nigeria Rebecca Marmot, Vice President, Global Partnerships, Unilever 11:10 am–12:10 pm Panel Discussion 12:10–1:00 Lunch 1:00 Part 2: Laying Out Some Governance Options: The Work of Concurrent Panels and Debate 1:00–1:40 Insights from Concurrent Initiatives Peter Piot, Director, London School of Hygiene & Tropical Medicine Joy Phumaphi, Executive Secretary of African Leaders Malaria Alliance, Member of UN High-Level Panel on Global Response to Health Crises 1:40–1:50 The Debate: Introduction Moderator: Larry Gostin 1:50–2:10 Model 1: WHO Status Quo Charles Clift 2:10–2:30 Model 2: "WHO Plus" WHO with an attached center for humanitarian and outbreak management under the line authority of the WHO Director-General and with strategic, operational, and tactical roles. It combines both strategic and operational missions within the WHO-Geneva culture.
|
From page 107... ...
• Identify financing mechanisms that help mobilize and maintain good governance and steer policy directions. 4:15–5:15 Panel Discussion Tim Evans, Senior Director, Health, Nutrition and Population Global Practice, World Bank Jeremy Farrar Daniel López-Acuña 5:15–5:45 Open Discussion 5:45–6:00 Concluding Remarks Eileen Choffnes, Scholar, Board on Global Health, IOM Ceci Mundaca-Shah, Senior Program Officer, Board on Global Health, IOM David Relman 6:00 Adjourn
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.